Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Subtype-Specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B Cell Lymphoma (DLBCL)

Blood (2024) 144 (Supplement 1): 2977.

https://doi.org/10.1182/blood-2024-208182

Published: 2024

Journal Articles

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Blood (2023) 142 (Supplement 1): 4140.

https://doi.org/10.1182/blood-2023-181974

Published: 2023

Journal Articles

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Melissa A. Hopper, Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, Miranda S. Laverty, Michelle Manske, Xiaosheng Wu, Kerstin Wenzl, Jordan Edward Krull, Vivekananda Sarangi, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Thomas E. Witzig, Stephen M Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak

Blood (2023) 142 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2023-180232

Published: 2023

Journal Articles

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Blood (2023) 142 (Supplement 1): 2770.

https://doi.org/10.1182/blood-2023-180949

Published: 2023

Journal Articles

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Rosalie Griffin, Kerstin Wenzl, Vivekananda Sarangi, Lisa M. Rimsza, Rebecca King, Andrew L. Feldman, Matthew J. Maurer, Grzegorz S. Nowakowski, Brian K. Link, Thomas M. Habermann, Nicholas Stong, C. Chris Huang, Anita K. Gandhi, Susan L. Slager, Anne J. Novak, James R. Cerhan

Blood (2023) 142 (Supplement 1): 1633.

https://doi.org/10.1182/blood-2023-182291

Published: 2023

Journal Articles

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Blood (2022) 140 (Supplement 1): 1742–1744.

https://doi.org/10.1182/blood-2022-159620

Published: 2022

Journal Articles

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 3548–3550.

https://doi.org/10.1182/blood-2022-170228

Published: 2022

Journal Articles

Molecular Landscape of Primary Refractory DLBCL

Blood (2022) 140 (Supplement 1): 9221–9223.

https://doi.org/10.1182/blood-2022-156497

Published: 2022

Journal Articles

Follicular Lymphoma Tumor-Cell Transcriptional Programs Associate with Distinct Somatic Alterations and Tumor-Immune Microenvironments

Jordan E. Krull, Kerstin Wenzl, Michelle K. Manske, Melissa A. Hopper, Melissa C. Larson, Vivekananda Sarangi, Matthew J. Maurer, Zhi-Zhang Yang, Lisa M. Rimsza, Brian K. Link, Thomas M. Habermann, Stephen M. Ansell, Rebecca L. King, James R. Cerhan, Anne J. Novak

Blood (2021) 138 (Supplement 1): 1327.

https://doi.org/10.1182/blood-2021-153873

Published: 2021

Journal Articles

Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome

Melissa A. Hopper, Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Joseph P. Novak, Michelle K. Manske, MaKayla R. Serres, Vivekananda Sarangi, Melissa C. Larson, Matthew J. Maurer, Jonas Paludo, Ellen D. McPhail, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Stephen M. Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak

Blood (2021) 138 (Supplement 1): 808.

https://doi.org/10.1182/blood-2021-147363

Published: 2021

Journal Articles

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Jordan Krull, BS, Kerstin Wenzl, PhD, Michelle Manske, MS, BS, Melissa Hopper, MSc, Melissa C. Larson, MS, Vivekananda Sarangi, Matthew J. Maurer, MS, Zhi-Zhang Yang, PhD, Lisa M. Rimsza, MD, Brian K. Link, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD PhD, Rebecca L. King, MD, James R. Cerhan, MD PhD, Anne J. Novak, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-142744

Published: 2020

Journal Articles

Clonal Somatic Mutations Are a Biomarker for Inferior Prognosis in Diffuse Large B-Cell Lymphoma

Nicholas J. Boddicker, PhD, Pinkal Desai, MDMPH, Mithun Vinod Shah, MD PhD, Vivekananda Sarangi, Matthew J. Maurer, MS, Elliot J. Cahn, Peter Martin, FRCPC, MD MS, Brian K. Link, MD, Thomas E. Witzig, MD, Andrew L. Feldman, MD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Susan L. Slager, PhD, C. Chris Huang, PhD, Fadi Towfic, PhD, Yan Asmann, PhD, Anita K Gandhi, PhD, Anne J. Novak, PhD, James R. Cerhan, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-141726

Published: 2020

Journal Articles

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Keenan T. Hartert, PhD, Kerstin Wenzl, PhD, Jordan Krull, Michelle Manske, MS, BS, Vivekananda Sarangi, Melissa C Larson, Theodora Anagnostou, MD, Ellen D. McPhail, MD, Brian K. Link, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Dragan Jevremovic, MD PhD, Anne J Novak, PhD

Blood (2019) 134 (Supplement_1): 2764.

https://doi.org/10.1182/blood-2019-128803

Published: 2019

Journal Articles

Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways

Blood (2019) 134 (Supplement_1): 1480.

https://doi.org/10.1182/blood-2019-126860

Published: 2019

Journal Articles

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Yan Asmann, PhD, Vivekananda Sarangi, MS, Chen Wang, PhD, Matthew J Maurer, MS, Stephen Ansell, MD PhD, Andrew L Feldman, MD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Anne J. Novak, PhD, Susan L. Slager, PhD, Brian K Link, MD, James Cerhan, MD PhD

Blood (2015) 126 (23): 131.

https://doi.org/10.1182/blood.V126.23.131.131

Published: 2015

Journal Articles

Genomic Diversity of Newly Diagnosed Follicular Lymphoma: a Pilot Investigation

Yan Asmann, PhD, Matthew J Maurer, MS, Vivekananda Sarangi, MS, Stephen M. Ansell, MD PhD, Andrew L. Feldman, MD, Grzegorz S. Nowakowski, MD, Michelle K Manske, Tammy Price Troska, BS, Zhi-Zhang Yang, MD, Susan L Slager, PhD, Thomas M Habermann, MD, James R Cerhan, MD PhD, Anne J. Novak, PhD

Blood (2014) 124 (21): 1691.

https://doi.org/10.1182/blood.V124.21.1691.1691

Published: 2014

Journal Articles

Comparison Of Single Nucleotide Mutations (SNVs) and Copy Number Variants (CNVs) Detection In Formalin Fixed Paraffin Embedded (FFPE) and Paired Frozen Tumor Tissues Using Target Capture and Sequencing Approach

Yan W Asmann, PhD, Vivekananda Sarangi, MS, Bruce W. Eckloff, Julie M Cunningham, Samantha J McDonough, Yeon K Lee, Eric D Wieben, PhD, Ahmet Dogan, MD, PhD, Andrew L. Feldman, Susan L Slager, PhD, James R Cerhan, MD, PhD, Anne J. Novak, PhD

Blood (2013) 122 (21): 1784.

https://doi.org/10.1182/blood.V122.21.1784.1784

Published: 2013

NARROW

Subtype-Specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B Cell Lymphoma (DLBCL)

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Molecular Landscape of Primary Refractory DLBCL

Follicular Lymphoma Tumor-Cell Transcriptional Programs Associate with Distinct Somatic Alterations and Tumor-Immune Microenvironments

Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Clonal Somatic Mutations Are a Biomarker for Inferior Prognosis in Diffuse Large B-Cell Lymphoma

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Genomic Diversity of Newly Diagnosed Follicular Lymphoma: a Pilot Investigation

Comparison Of Single Nucleotide Mutations (SNVs) and Copy Number Variants (CNVs) Detection In Formalin Fixed Paraffin Embedded (FFPE) and Paired Frozen Tumor Tissues Using Target Capture and Sequencing Approach

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only